Comparative analysis of ctDNA-MRD and MVI in predicting postoperative recurrence of hepatocellular carcinoma: a prospective multicenter cohort study.
Blood-based minimal residual disease tracking outperformed traditional imaging for predicting which liver cancer patients will relapse.
This prospective multicenter cohort study examined comparative analysis of ctdna-mrd and mvi in predicting postoperative recurrence of hepatocellular carcinoma: a prospective multicenter cohort study. The PubMed abstract reports longitudinal ctdna minimal-residual-disease status outperformed microvascular invasion for predicting recurrence after hepatocellular carcinoma resection, with the combined model reaching auc values of 0853 to 0899.
What the study was
- Study design
- Prospective multicenter cohort study
- Population
- Patients undergoing curative resection for hepatocellular carcinoma
- Category
- Genomics/Precision Medicine
- Maturity
- Validated
- Journal
- Hepatology international
Why it surfaced
Score reflects the prospective multicenter cohort study design and relevance to Precision oncology and genomic medicine; classification is limited to PubMed title, metadata, and abstract evidence.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.